- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Equine PA antibody and antigen (recombinant protein)
Diagnostic anti-Equine PA antibodies pairs and antigen for animal health (animal Equine/Horse liver disease, inflammation, or tissue death) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-EQU-PA-Ag01 | Equine PA | $3090.00 |
| GMP-EQU-PA-Ab01 | Anti-Equine PA mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-PA-Ab02 | Anti-Equine PA mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-PA-Ab03 | Anti-Equine PA human monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-PA-Ab04 | Anti-Equine PA human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-EQU-PA-Ag01 |
| Product Name | Equine PA |
| Target/Biomarker | Equine PA |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Equine PA antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PA level test of animal Equine/Horse with liver disease, inflammation, or tissue death. |
| Tag | His | Reconized/Reactive Specics | Equine PA |
| Product description | Recombinant Equine PA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-PA-Ab01,GMP-EQU-PA-Ab02 |
| Target/Biomarker | Equine PA |
| Product Name | Anti-Equine PA mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Equine PA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PA antibodies in Equine PA level test of animal Equine/Horse with liver disease, inflammation, or tissue death. |
| Product description | Anti-Equine PA mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PA antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-PA-Ab03,GMP-EQU-PA-Ab04 |
| Target/Biomarker | Equine PA |
| Product Name | Anti-Equine PA human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Equine PA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine PA antibodies in Equine PA level test of animal Equine/Horse with liver disease, inflammation, or tissue death. |
| Product description | Anti-Equine PA mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Equine Prothrombin Activation Fragment 1+2 (ePAF1+2) represents a crucial piece of the puzzle within the intricate world of equine hemostasis. Structurally, it arises as a fragment resulting from the activation of prothrombin (Factor II) into thrombin (Factor IIa), a process meticulously orchestrated by a cascade of coagulation factors and platelet interactions. This activation event is the cornerstone of blood clot formation, which is essential for maintaining hemostasis in horses.
Prothrombin, an inactive precursor protein, circulates silently in the equine bloodstream until it encounters vascular injury. When such an injury occurs, a precisely choreographed sequence of enzymatic reactions is initiated, culminating in the cleavage of prothrombin into two fragments: thrombin and ePAF1+2. Thrombin, the multifunctional enzyme generated through this process, takes center stage in the creation of a stable blood clot. It catalyzes the conversion of soluble fibrinogen into insoluble fibrin strands, which provide the structural framework of a clot.
ePAF1+2, while not directly involved in clot formation, plays a critical role as a marker of ongoing thrombin generation within the equine hemostatic system. Its presence in circulation reflects the dynamic equilibrium between prothrombin activation and thrombin regulation, offering insights into the coagulation status of horses.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
